European market for pharmaceutical software solutions grows

The European market plays an important role in shaping the future of the global pharmaceutical industry.

Jim Langford
President
DataLabs

By Anna Rooke, OurWorld Editor

DataLabs develops innovative software applications for clinical trials that help pharmaceuticals firms develop new products more quickly and with fewer resources.

In response to the continuing global growth of the clinical trials industry, the firm has decided to open a European office in Reading.

Europe a key market for pharmaceutical industry

According to DataLabs an increasing number of US companies are locating overseas.

For Datalabs Europe is a priority market because European pharma companies are emerging as industry leaders.

“The European market plays an important role in shaping the future of the global pharmaceutical industry,” commented Jim Langford, president of DataLabs.

Growing internationally

The UK base will enable Datalabs to take advantage of global opportunities in the pharmaceuticals sector.

“Not only does the opening of DataLabs’ new European office extend our company’s global reach, but more importantly, it positions DataLabs to better support the increasing needs of our valued global clients,” said Langford.